07:00 , Jun 30, 2014 |  BC Week In Review  |  Company News

Cipla, Hetero Drugs deal

Hetero granted Cipla non-exclusive commercialization rights to Actorise darbepoetin alfa, a biosimilar of Aranesp darbepoetin alfa, in India, where Cipla launched the product to treat anemia caused by chronic kidney disease (CKD). Hetero...